Fortenberry J D, Bhardwaj V, Niemer P, Cornish J D, Wright J A, Bland L
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
J Pediatr. 1996 May;128(5 Pt 1):670-8. doi: 10.1016/s0022-3476(96)80133-8.
To determine whether extracorporeal membrane oxygenation (ECMO), like cardiopulmonary bypass, produces systemic inflammatory responses that could potentiate organ injury in infants with respiratory failure.
We evaluated the effects of neonatal ECMO on neutrophil surface adherence proteins, elastase release, and cytokine levels in blood samples from 15 patients before and during ECMO, and from banked blood and ECMO circuit blood before cannulation. Neutrophil elastase, tumor necrosis factor alpha, and interleukin types 1 beta, 6, and 8 were measured. Chest radiographs were evaluated by a radiologist using a lung injury score in blinded fashion.
Primed ECMO circuit blood, in comparison with patient pre-ECMO blood, demonstrated marked up-regulation of CD11b (mean fluorescence intensity 1660 +/- 109 vs 361 +/- 81; p < 0.001 (mean +/- SEM)), shedding of L-selectin (mean fluorescence intensity 10 +/- 2 vs 89 +/- 38; p < 0.01), and elevated elastase levels (349 +/- 76 vs 154 ng/ml +/- 38; p < 0.001), consistent with neutrophil activation. During ECMO, neutrophil CD11b levels increased but L-selectin was not significantly shed. Concentrations of circulating neutrophil elastase increase significantly during ECMO. Corrected circulating quantities of interleukin-8 also rose significantly, but the responses of tumor necrosis factor alpha and interleukin-1 beta were minimal. Radiographic lung injury scores worsened with the initiation of ECMO (median score: 6 before ECMO vs 11 in first hour of ECMO; p = 0.012), in conjunction with indicators of neutrophil activation.
Neonates with respiratory failure have activation of the inflammatory cascade. ECMO incites additional neutrophil and cytokine activation in association with early pulmonary deterioration. Routine leukodepletion of blood for circuit priming to remove activated neutrophils may be beneficial.
确定体外膜肺氧合(ECMO)是否像体外循环一样,引发全身炎症反应,从而加重呼吸衰竭婴儿的器官损伤。
我们评估了新生儿ECMO对15例患者体外膜肺氧合治疗前、治疗期间以及插管前库存血和体外循环回路血中中性粒细胞表面黏附蛋白、弹性蛋白酶释放及细胞因子水平的影响。检测了中性粒细胞弹性蛋白酶、肿瘤坏死因子α以及白细胞介素1β、6和8。放射科医生采用盲法根据肺损伤评分对胸部X光片进行评估。
与患者体外膜肺氧合治疗前的血液相比,预充后的体外循环回路血显示CD11b显著上调(平均荧光强度1660±109对361±81;p<0.001(平均值±标准误)),L-选择素脱落(平均荧光强度10±2对89±38;p<0.01),弹性蛋白酶水平升高(349±76对154 ng/ml±38;p<0.001),这与中性粒细胞活化一致。在体外膜肺氧合治疗期间,中性粒细胞CD11b水平升高,但L-选择素未显著脱落。体外膜肺氧合治疗期间循环中性粒细胞弹性蛋白酶浓度显著增加。校正后的循环白细胞介素-8量也显著升高,但肿瘤坏死因子α和白细胞介素-1β的反应极小。随着体外膜肺氧合治疗的开始,胸部X光片肺损伤评分恶化(中位数评分:体外膜肺氧合治疗前为6分,体外膜肺氧合治疗第一小时为11分;p=0.012),同时伴有中性粒细胞活化指标。
呼吸衰竭新生儿存在炎症级联反应激活。体外膜肺氧合引发额外的中性粒细胞和细胞因子活化,并伴有早期肺部恶化。常规对回路预充血液进行白细胞滤除以去除活化的中性粒细胞可能有益。